Microsoft word - fellows publications 2006-12.doc

Duke Fellows’ Publications
1st or 2nd author, peer-reviewed
1. Adams GL, Ambati SR, Adams JM, Borges-Neto S. Role of nuclear imaging
after coronary revascularization. J Nucl Cardiol. 2006 Mar-Apr;13(2):163-9 2. Adams GL, Campbell PT, Adams JM, Strauss DG, Wall K, Patterson J, Shuping
KB, Maynard C, Young D, Corey C, Thompson A, Lee BA, Wagner GS. Effectiveness of prehospital wireless transmission of electrocardiograms to a cardiologist via hand-held device for patients with acute myocardial infarction (from the Timely Intervention in Myocardial Emergency, NorthEast Experience [TIME-NE]). Am J Cardiol. 2006 Nov 1;98(9):1160-4. 3. Albert TS, Kim RJ, Judd RM. Assessment of no-reflow regions using cardiac
MRI. Basic Res Cardiol. 2006 Sep;101(5):383-90. 4. Allen LA, O'Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM.
Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J. 2006 May;151(5):1065-71. 5. Echols MR, Felker GM, Thomas KL, Pieper KS, Garg J, Cuffe MS, Gheorghiade
M, Califf RM, O'Connor CM. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial. J Card Fail. 2006 Dec;12(9):684-8. 6. Gharacholou SM, Alexander KP. Issues with care in the elderly patient
presenting with acute ischemia.Curr Heart Fail Rep. 2006 Jun;3(2):51-6. 7. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux
P, Oliveira GB, Todaro TG, Mojcik CF, Armstrong PW, Granger CB. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006 Jun;27(11):1289-97. 8. Nilsson KR, Gharacholou SM, Sketch MH Jr, Krucoff MW. Simultaneous
restenosis of Taxus and Cypher drug-eluting stents. J Invasive Cardiol. 2006 Nov;18(11):557-60. 9. Patel MR, Meine TJ, Lindblad L, Griffin J, Granger CB, Becker RC, Van de
Werf F, White H, Califf RM, Harrington RA. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. Am Heart J. 2006 Feb;151(2):316-22. 10. Patel MR, Donahue M, Wilson PW, Califf RM. Clinical trial issues in weight-
loss therapy. Am Heart J. 2006 Mar;151(3):633-42 11. Patel MR, Albert TS, Kandzari DE, Honeycutt EF, Shaw LK, Sketch MH Jr,
Elliott MD, Judd RM, Kim RJ. Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents. Radiology. 2006 Sep;240(3):674-80. 12. Patel MR, Albert TS, Kandzari DE, Honeycutt EF, Shaw LK, Sketch MH Jr,
Elliott MD, Judd RM, Kim RJ. Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents. Radiology. 2006 Sep;240(3):674-80. 13. Meine TJ, Patel MR, Shaw LK, Borges-Neto S. Relation of ventricular premature
complexes during recovery from a myocardial perfusion exercise stress test to myocardial ischemia. Am J Cardiol. 2006 Jun 1;97(11):1570-2. 14. Valente AM, Bashore TM. Unusual cardiomyopathies: ventricular
noncompaction and takotsubo cardiomyopathy. Rev Cardiovasc Med. 2006 Summer;7(3):111-8. 15. Singh KP, Patel MR, Kandzari DE, Zidar JP. Peripheral arterial disease: an
overview of endovascular therapies and contemporary treatment strategies. Rev Cardiovasc Med. 2006 Spring;7(2):55-68. 16. Singh KP, Roe MT, Peterson ED, Chen AY, Mahaffey KW, Goodman SG,
Harrington RA, Smith SC Jr, Gibler WB, Ohman EM, Pollack CV Jr; CRUSADE Investigators. Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative. J Thromb Thrombolysis. 2006 Jun;21(3):211-20. 17. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK,
Wians F, Sabatine MS, Morrow DA, de Lemos JA. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006 Apr 25; 113 (16): 1958-65. 18. Wolf MJ, Amrein H, Izatt JA, Choma MA, Reedy MC, Rockman HA.
Drosophila as a model for the identification of genes causing adult human heart disease. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1394-9. 19. Volovyk ZM, Wolf MJ, Prasad SV, Rockman HA. Agonist-stimulated beta-
adrenergic receptor internalization requires dynamic cytoskeletal actin turnover. J Biol Chem. 2006 Apr 7;281(14):9773-80. 1. Adams GL, Manson RJ, Turner I, Sindram D, Lawson JH. The balance of
thrombosis and hemorrhage in surgery. Hematol Oncol Clin North Am. 2007 Feb;21(1):13-24. 2. Adams GL, Shaw LK, Tuttle RH, Hanson MW, Pagnanelli R, Borges-Neto S.
Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi. Nucl Med Commun. 2007 Jun;28(6):457-63. 3. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA,
Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB; CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 Jul 3;50(1):40-7. 4. Allen LA, O'Connor CM. Management of acute decompensated heart failure.
5. Atwater B, S. Milford-Bland, L. Newby, A. Hernandez, F. Peacock, W. Gibler,
R. Christensen, E. Ohman, E. Peterson, M. Roe: Patterns and implications of B- type natriuretic peptide measurement in patients with non-st-elevation acute coronary syndromes. Am J Cardiol 2007 100(12): 1727-33. 6. Brennan JM, JEA Blair, C Hampole, S Goonewardena, S Vasaiwala, D Shah, K
Spencer, GA Schmidt. Radial Artery Pulse Pressure Variation Correlates with Brachial Artery Peak Velocity Variation in Ventilated Subjects When Measured by Internal Medicine Residents Using Hand-Carried Ultrasound Devices. Chest. 2007; 131:1301–1307 7. Brennan JM, J Blair, S Goonewardena, A Ronan, D Shah, S Vasaiwala, E
Brooks, A Levy, JN Kirkpatrick, KT Spencer. A Comparison by Medicine Residents of Physical Examination vs. Hand-Carried Ultrasound for Estimation of Right Atrial Pressure. Am J Cardiol. 2007; 99 (11):1614-6 8. Brennan JM, JE Blair, S Goonewardena, A Ronan, D Shah, S Vasaiwala, JN
Kirkpatrick, KT Spencer. Reappraisal of the Use of IVC for Estimating Right Atrial Pressure. J Am Soc Echocardiogr. 2007; 20 (7):857-61. 9. Frazier CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, Cohn
J, Goldstein S, Douglas PS. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J Am Coll Cardiol. 2007 Apr 3;49(13):1450-8. 10. Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf
RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB Jr, Peterson ED; PREVENT IV Investigators. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg. 2007 Mar;83(3):993-1001. 11. Jones WS, Annex BH. Growth factors for therapeutic angiogenesis in peripheral
arterial disease. Curr Opin Cardiol. 2007 Sep;22(5):458-63. 12. Katz JN, Turer AT, Becker RC. Cardiology and the critical care crisis: a
perspective. J Am Coll Cardiol. 2007 Mar 27;49(12):1279-82. 13. Patel MJ, de Lemos JA, Philips B, Murphy SA, Vaeth PC, McGuire DK, Khera
A. Implications of family history of myocardial infarction in young women. Am Heart J. 2007 Sep;154(3):454-60. 14. Vavalle JP, Wu SS, Hughey R, Madamanchi NR, Stouffer GA. Plasma
fibronectin levels and coronary artery disease. J Thromb Haemost. 2007 Apr;5(4):864-6. 15. Rehwald WG, Salerno M, Chen EL, Sievers B, Kim RJ, Judd RM. Combining
spin echoes with gradient echoes in the context of the global coherent free precession pulse sequence. Magn Reson Med. 2007 Jul;58(1):82-91. 16. Shah, BR, Schulman, K. “What are the regulatory and economic challenges
posed by drug-eluting stents?” Dialogues in Cardiovascular Medicine,13 (4), 15-
20.
17. Shah, BR, Patel, MP, Peterson ED, Douglas, PD. “Defining Optimal Research
Study Design for Cardiovascular Imaging Using Computed Tomography Angiography as a Model.” American Journal of Cardiology, 102(7): 943-8. 18. Peterson ED, Shah BR, Parson L, Pollack CB, French WJ, Gibson CM, Rogers
WJ. “Trends in Quality of Care for Patients with Acute Myocardial Infarction from 1990 to 2006: from the National Registry of Myocardial Infarction Database.” American Heart Journal, 156:1045-1055. 19. Thomas KL, Al-Khatib SM, Kelsey RC 2nd, Bush H, Brosius L, Velazquez EJ,
Peterson ED, Gilliam FR. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35%. Am J Cardiol. 2007 Sep 15;100(6):924-9. 20. Trimble MA, Borges-Neto S, Smallheiser S, Chen J, Honeycutt EF, Shaw LK,
Heo J, Pagnanelli RA, Tauxe EL, Garcia EV, Esteves F, Seghatol-Eslami F, Kay GN, Iskandrian AE. Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging in patients with left ventricular dysfunction and conduction disturbances. J Nucl Cardiol. 2007 May-Jun;14(3):298-307. 21. Trimble MA, Sketch MH Jr, Mehta RH. Hemolytic anemia: a rare but potentially
serious adverse effect of captopril. Herz. 2007 Feb;32(1):62-4. 22. Turer AT, Mahaffey KW, Compton KL, Califf RM, Schulman KA. Publication
or presentation of results from multicenter clinical trials: evidence from an academic medical center. Am Heart J. 2007 Apr;153(4):674-80. 23. Wallace TW, Rao SV. The challenge of defining bleeding among patients with
acute coronary syndromes. Clin Cardiol. 2007; 30 (10 Suppl 2): II16-23. 24. Wang TY, Hasselblad V, Petersen JL, Wijns W, Parhizgar A, Kereiakes DJ,
Krucoff MW. The Cobalt chromium STent with Antiproliferative for Restenosis (COSTAR) II Trial Study Design: advancing the active-control evaluation of second-generation drug-eluting stents. Am Heart J 2007;153:743-8 25. Wang TY, Chen AY, Roe MT, Alexander KP, Newby LK, Smith SC, Bangalore
S, Gibler WB, Ohman EM, Peterson ED. Increased bleeding risk in Asian patients with non-ST-segment elevation acute coronary syndromes: Insights from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines) National Quality Improvement Initiative. Am J Cardiol 2007;100:391 26. Wang TY, Robinson LA, Ou F, Roe MT, Ohman EM, Gibler WB, Peterson ED,
Becker RC. Discharge antithrombotic strategies among patients with acute coronary syndromes on warfarin anticoagulation at initial hospitalization. Am Heart J 2007; 155: 361. 1. Adams GL, Manson RJ, Giangiacomo DM, Fronheiser L, McCall S, Nightingale
R, Hasselblad V, Shaw LK, Milton L, Lawson JH. Effectiveness of Glycerol Mono-oleate as a Biosealant. J Invasive Cardiol. 2008 Jan;20(1):29-34. 2. Adams GL, Manson RJ, Hasselblad V, Shaw LK, Lawson JH. Acute in-vivo
evaluation of bleeding with Gelfoam(TM) plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine. J Thromb Thrombolysis. 2008 Jul 16. 3. Washam JB, Adams GL. Risks and benefits of antiplatelet therapy in uremic
patients. Adv Chronic Kidney Dis. 2008 Oct;15(4):370-7. 4. Adams GL, Trimble MA, Brosnan RB, Russo CA, Rusband D, Honeycutt EF,
Shaw LK, Hurwitz LM, Turkington TG, Hanson MW, Pagnanelli RA, Borges- Neto S. Evaluation of combined cardiac positron emission tomography and coronary computed tomography angiography for the detection of coronary artery disease. Nucl Med Commun. 2008 Jul;29(7):593-8. 5. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli
A, Judd RM; Gadoversetamide Myocardial Infarction Imaging Investigators. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008 Feb 5;117(5):629-37. 6. Allen LA, Rogers JG, Warnica JW, Disalvo TG, Tasissa G, Binanay C, O'Connor
CM, Califf RM, Leier CV, Shah MR, Stevenson LW; Escape Investigators and Coordinators. High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization. J Card Fail. 2008 Oct;14(8):661-9. 7. Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, Dodson GC,
O'Connor CM, Felker GM. Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008 Jun 4;299(21):2533-42. 8. Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly.
9. Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr
10. Atwater B, L. Nee, G. Gimelli: Long-term survival using intraaortic balloon
pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock. J Inv Cardiol 2008 20(7): E205-7. 11. Atwater B, Z. Ai, M. Wolff: Fulminant myopericarditis from phenytoin-induced
systemic lupus erythematosus. Wisc Med J 2008 107(6): 298-300. 12. Berger JS, Bairey-Merz CN, Redberg RF, Douglas PS; Improving the quality of
care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007. DCRI Think Tank. Am Heart J. 2008 Nov;156(5):816-25. 13. Berger JS, Stebbins A, Granger CB, Ohman EM, Armstrong PW, Van de Werf
F, White HD, Simes RJ, Harrington RA, Califf RM, Peterson ED. Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy. Circulation. 2008 Jan 15;117(2):192-9. 14. Berger JS, Brown DL, Becker RC. Low-dose aspirin in patients with stable
cardiovascular disease: a meta-analysis. Am J Med. 2008 Jan;121(1):43-9. 15. Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC. Impact
of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. J Am Coll Cardiol. 2008 Nov 18;52(21):1693-701. 16. Berger JS, Bairey-Merz CN, Redberg RF, Douglas PS; DCRI Think Tank.
Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007. Am Heart J. 2008 Nov;156(5):816-25. 17. Brennan JM, JL Petersen. Early Intervention: Which Patients and How Early?
Current Cardiology Reports. 2008 Jul;10(4):303-11. 18. Hess, C, Kou R, Johnson RP, Li GK, Michel T. ADP signaling in vascular
endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase. J Biol Chem. 2009 Nov 20;284(47):32209-24. 19. Kong MH, Corey GR, Bashore T, Harrison JK. Clinical problem-solving. A key
miscommunication —an 81-year-old woman presented to the emergency department with increasing abdominal distention, nausea, and vomiting. N Engl J Med 2008;358(10):1054-9. 20. Konstance RP, Eisenstein EL, Anstrom KJ, Shaw LK, Califf RM, Harrington
RA, Matchar DB, Schulman KA, Kong DF. Outcomes of second revascularization procedures after stent implantation. J Med Syst. 2008 Apr;32(2):177-86. 21. Nilsson KR, Sewell PM, Blunden-Kasdorf P, Starkey K, Grant AO, Wagner GS.
The influence of cardiograph design and automated algorithms on the incidence and detection of electrode cable reversals in an academic electrocardiogram laboratory. J Electrocardiol. 2008 Sep-Oct;41(5):382-7. 22. Nilsson KR, Duscha BJ, Hranitzky PM and Kraus WE. Chronic Heart Failure
and Exercise Intolerance – The Hemodynamic Paradox. Current Cardiology Reviews. 2008 May. Vol. 4 (2): 92-100. 23. Nilsson KR, Bennett V. Patterning of Membrane Based Microdomains: New
Insights into a Novel Class of Cardiovascular Diseases. In Press, The Journal of Cardiovascular Pharmacology. 24. Purcell JB, Patel M, Khera A, de Lemos JA, Forbess LW, Baker S, Cabell CH,
Peterson GE. Relation of troponin elevation to outcome in patients with infective endocarditis. Am J Cardiol. 2008 May 15;101(10):1479-81. 2008 Mar 17. 25. Piccini JP, Hranitzky PM, Kilaru K, Rouleau JL, White HD, Aylward PE, Van de
Werf F, Solomon SD, Califf RM, Velazquez EJ. Relation of Mortality to Failure to Prescribe ß-blockers Acutely in Patients with Sustained Ventricular Tachycardia and Ventricular Fibrillation following Acute Myocardial Infarction (From the VALIANT Registry). Am J Cardiol. 2008;102:1427-32. 26. Piccini JP, Horton JR, Shaw LK, Al-Khatib SM, Lee KL, Iskandrian A, Borges-
Neto S. SPECT Myocardial Perfusion Defects Are Associated with an Increased Risk of All-Cause Death, Cardiovascular Death and Sudden Cardiac Death. Circ Cardiovasc Imaging. 2008;1:180-188. 27. Piccini JP, Berger JS, Brown DL. Early Sustained Ventricular Arrhythmias
Complicating Acute Myocardial Infarction. Am J Med. 2008 Sep;121:797-804. 28. Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson
ED, Fonarow GC; for the Get With the Guidelines Steering Committee and Hospitals. Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure. Circulation. 2008 Aug 26;118:926-33. 29. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM.
Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol. 2009;2:626-33. 30. Samad Z, Wang TY, Frazier CG, Shah SH, Dolor RJ, Newby LK. Closing the
gap: treating hypertension in women. Cardiol Rev. 2008 Nov-Dec;16(6):305-13. 31. Shah BR, Peterson ED, Chen AY, Mahaffey KW, DeLong E, Ohman EM,
Pollack CV, Gibler WB, Roe MT. “Influence of Clinical Trial Participation on Subsequent Anti-Thrombin Use for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: Patterns of Enoxaparin vs. Unfractionated Heparin Use in the CRUSADE Initiative.” Accepted at Clinical Cardiology. 32. Shah, BR, Hernandez A, Liang, L, Al-Khatib, SM, Yancy, CW, Fonarow, GC,
Peterson, ED. “Hospital variation and characteristics of ICD implantation in
eligible patients with heart failure: Data from the GWTG-HF Registry.” Journal
of the American College of Cardiology, 53:416-422.
33. Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray
JJ, Califf RM, Velazquez EJ. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. Am Heart J. 2008 Jan;155(1):87-93. 34. Trimble MA, Velazquez EJ, Adams GL, Honeycutt EF, Pagnanelli RA, Barnhart
HX, Chen J, Iskandrian AE, Garcia EV, Borges-Neto S. Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl Med Commun. 2008 Apr;29(4):374-81. 35. Trimble MA, Borges-Neto S, Velazquez EJ, Chen J, Shaw LK, Pagnanelli R,
Garcia EV, Iskandrian AE. Emerging role of myocardial perfusion imaging to evaluate patients for cardiac resynchronization therapy. Am J Cardiol. 2008 Jul 15;102(2):211-7. 36. Trimble MA, Borges-Neto S, Honeycutt EF, Shaw LK, Pagnanelli R, Chen J,
Iskandrian AE, Garcia EV, Velazquez EJ. Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. J Nucl Cardiol. 2008 Sep-Oct;15(5):663-70. 37. Voora D, Shah SV, Reed CR, Zhai J, Crosslin Dr, Messer C, Salisbury BA,
Ginsburg GS. Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response. Circ Cardiovasc Genet, Dec 2008; 1: 100 - 106. 1. Atwater B, J Oujiri, M Wolff: The Immediate Impact of the Clinical Outcomes
Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial on the Management of Stable Angina. Clin Cardiol 2009 32 (3): pages pending publication 2. Douglas, P. S., Brennan, J. M., Anstrom, K. J., Sedrakyan, A., Eisenstein, E. L.,
Haque, G., Dai, D., Kong, D. F., Hammill, B., Curtis, L., Matchar, D., Brindis, R., Peterson, E. D. (2009). Clinical Effectiveness of Coronary Stents in Elderly Persons: Results From 262,700 Medicare Patients in the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol 2009;53: 1629-1641 3. John E. Blair, Brennan JM, Sascha N. Goonewardena, Dipak Shah, Samip
Vasaiwala, Kirk T Spencer. Usefulness of Hand-carried Ultrasound to Predict Elevated Left Ventricular Filling Pressure. AJC. 2009 103(2):246-7. 4. Eapen Z, Rogers JG. Strategies to attenuate pathological remodeling in heart
failure. Curr Opin Cardiol. 2009;24:223-9. 5. Gharacholou SM, Becker RC. Hemostasis and thrombosis in older adults. J
6. Halim SA, Mulgund J, Chen AY, Roe MT, Peterson Ed, Gibler WB, Ohman EM,
Newby LK. Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADE. Circ Cardiovasc Qual Outcomes. 2009;2:199-206. 7. Kaul P, Douglas PS. Atherosclerosis imaging: prognostically useful or merely
more of what we know? Circ Cardiovasc Imaging. 2009 Mar;2(2):150-60. 8. Nilsson KR JR, Bennett V. Ankyrin-based patterning of membrane
microdomains: new insights into a novel class of cardiovascular diseases. J Cardiovasc Pharmacol 209;54(2):106-15. 9. Nilsson KR JR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP,
Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) trial. Heart 2010;96:838-42. 10. Healy JA, Nilsson KR, Hohmeier HE, Berglund J, Davis J, Hoffman J, Kohler M,
Li LS, Berggren PO, Newgard CB, Bennett V. Cholinergic augmentation of insulin release requires ankyrin B. Sci Signal. 2010;3:ra19. 11. Kiefer T, Becker RC. Inhibitors of platelet adhesion. Circulation
12. Kociol R, Rogers J, Sahw A. Organ cross talk in the critically ill: the heart and
13. Lima B*, Lam GK,* Xie L, Diesen DL, Villamizar N, Neinaber J, Messina E,
Bowles D, Kontos CD, Hare JM, Stamler JS, Rockman HA (*co-first authors). Endogenous S-nitrosothiols protect against myocardial injury. Proceedings of the National Academy of Sciences of the United States of America. 2009 Mar 26. 14. Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF.
Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation. J. Am. Coll. Cardiol. 2009;54;1089-1095. 15. Piccini JP, Hafley GE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN,
Buxton AE. Mode of Induction of Ventricular Tachycardia and Prognosis in patients with Coronary Disease: The Multicenter UnSustained Tachycardia Trial (MUSTT). J Cardiovasc Electrophysiol. 2009; in press. 16. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, Lefkowitz
RJ. {beta}-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci U S A. 2009 Dec 17. 17. Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY,
Gibler B, Ohman EM, Roe MT, Pollack CV, Peterson ED, Alexander KP. Baseline risk of major bleeding in non-ST segment elevation myocardial infarction. Circulation 2009;119:1873-82. 18. Voora D, Shah SH, Spasojevic I, Ali S, Reed CR, Salisbury BA, Ginsburg GS.
The SLCO1B1*5 genetic variant is associated with statin-induced side effects. J Am Coll Cardiol. 2009 Oct 20;54(17):1609-16. 18. Turer AT, Mahaffey KW, Honeycutt E, Tuttle RH, Shaw LK, Sketch MH Jr,
Smith PK, Califf RM, Alexander JH. Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease. J Thorac Cardiovasc Surg. 2009 Jun;137(6):1468-74. 19. Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, Mathew
JP, Schwinn DA, Glower DD, Newgard CB, Podgoreanu MV. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation 2009;119:1736-46. 20. Wallace TW, Berger JS, Wang A, Velazquez EJ, Brown DL. Impact of left
ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. Am J Cardiol. 2009 Feb 1;103(3):355-60. 21. Zidar DA, Violin JD, Whalen EJ, Lefkowitz RJ. Selective engagement of G
coupled receptor kinases encodes distinct functions of biased ligands. Proc Natl Acad Sci USA, 2009, in press. 1. Bloomfield GS, Huffman MD. Global chronic disease research training for
fellows: perspectives, challenges, and opportunities. Circ 2010;121:1365-70. 2. Samad Z, Kaul P, Shaw LK, Glower DD, Velazquez EJ, Douglas PS, Jollis JG.
Impact of early surgery on survival of patients with severe mitral regurgitation. Heart. 2010 Nov 11. 3. Kaul P, Medvedev S, Hohmann SF, Douglas PS, Peterson ED, Patel MR.
Ionizing Radiation Exposure to Patients Admitted With Acute Myocardial Infarction in the United States. Circulation. 2010 Nov 8. [Epub ahead of print]PMID: 21060076 4. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered
classification of left ventricular hypertrophy based on LV geometry: the Dallas Heart Study. Circ Cardiovasc Imaging 2010 Mar 3(2): 164-71. 5. Kociol RD, Greiner MA, Hammill BG, Phatak H, Fonarow GC, Curtis LH,
Hernandez AF. Long-term outcomes of Medicare beneficiaries with worsening renal function during hospitalization for heart failure. Am J Cardiol. 2010;105:1786-93. 6. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O’connor CM, Felker.
Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. JACC, 2010;56:1071-8. 7. Kong MH, Peterson Ed, Fonarow GC, Sanders GD, Yancy CW, Russo AM,
Curtis AB, Sears SF et al. Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies. Am Heart J 2010;160:605-18. 8. Kong MH, Shaw LK, O’Connor C, Califf RM, Blazing MA, Al-Khatib SM. Is
rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure? Ann Noninvasive Electrocardiol 2010;15:209-17. 9. Sanders GD, Kong MH, Al-Khatib SM, Peterson ED. Cost-effectiveness of
implantable cardioverter defibrillators in patients > or = 65 years of age. Am Heart J. 2010;160:122-31. 10. Kong MH, Lopes RD, Piccini JP, Hasselblad V, Bahnson TD, Al-Khatib SM.
Surgical Maze procedure as a treatment for atrial fibrillation: A meta-analysis of randomized controlled trials. Cardiovasc Ther. 2010. 11. Kong MH, Piccini JP, Bahnson TD. Efficacy of adjunctive ablation of complex
fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials. Europace. 2010 Oct 30. 12. Mentz, RJ, Lewis EF. Epidemiology of cardiorenal syndrome. Heart Fail Clin
13. Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks:
biasing seven-transmembrane receptors. Nat Rev Drug Discov. 2010;9:376-86. 14. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Lefkowitz RJ. Beta-
arrestin--but not G protein--mediated signaling by the “decoy” receptor CXCR7. Proc Natl Acad Sci. 2010;107:628-32. 15. Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM.
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. Am J Cardiol. 2010 Jun 15;105(12):1794-7. 16. Turer AT, Samad Z, Valente AM, Parker MA, Hayes B, Kim RJ, Kisslo J, Wang
A. Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy. Eur J Echocardiogr. 2010 Nov 1. PMID: 21044981 17. Turer AT, Malloy CR, Newgard CB, Podgoreanu MV. Energetics and
metabolism in the failing heart: important but poorly understood. Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):458-65. 18. Vavalle JP, Rao SV. The association between the transradial approach for
percutaneous coronary interventions and bleeding. Journal of Invasive Cardiology. 2009 Aug; 21(Suppl A): 21A-24A 19. Voora D, Koboldt DC, King CR, Lenzini PA, Eby CS, Porche-Sorbet R, Deych
E, Crankshaw M, Milligan PE, McLeod HL, Patel SR, Cavallari LH, Ridker PM, Grice GR, Miller RD, Gage BF. A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. Clin Pharmacol Ther. 2010 Apr;87(4):445-51. 1. Tariq Ahmad, Deepak Voora, Richard Becker. The Pharmacogenetics of Anti-
Platelet Agents: Towards Personalized Therapies? Nature Cardiology Reviews. Epub Aug 9 2011. 2. Tariq Ahmad, Robert Mentz, G. Michael Felker, Joseph G. Rogers, Chetan B.
Patel. Recurrence of Heart Failure Symptoms after LVAD Placement due to Bradycardia Induced Inflow Obstruction. Journal of Heart and Lung Transplantation. Epub Oct 12 2011. 3. Eapen ZJ, Fonarow GC, Dai D, O'Brien SM, Schwamm LH, Cannon CP,
Heidenreich PA, Bhatt DL, Peterson ED, Hernandez AF; for the Get With The Guidelines Steering Committee and Hospitals. Comparison of Composite Measure Methodologies for Rewarding Quality of Care: An Analysis From the American Heart Association's Get With The Guidelines Program. Circ Cardiovasc Qual Outcomes. 2011 Nov 1;4(6):610-618. Epub 2011 Oct 18. 4. Reed SD, Eapen ZJ, Schulman KA. End point selection in acute decompensated
heart failure clinical trials: economic end points. Heart Fail Clin. 2011 Oct;7(4):529-37. 5. Eapen ZJ, Peterson ED, Fonarow GC, Sanders GD, Yancy CW, Sears SF Jr,
Carlson MD, Curtis AB, Hall LL, Hayes DL, Hernandez AF, Mirro M, Prystowsky E, Russo AM, Thomas KL, Al-Khatib SM. Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice. Am Heart J. 2011 Aug;162(2):222-31. Epub 2011 Jul 7. Review. 6. Eapen ZJ, Reed SD, Curtis LH, Hernandez AF, Peterson ED.Do heart failure
disease management programs make financial sense under a bundled payment system? Am Heart J. 2011 May;161(5):916-22. 7. Halim SA, Rao SV.Bleeding and acute coronary syndromes: defining, predicting,
and managing risk and outcomes. Curr Drug Targets. 2011 Nov;12(12):1831-5. 8. Kiefer T.L. and Bashore T.M. Pulmonary hypertension related to left-sided
cardiac pathology. Pulmonary Medicine, 2011:1-11, 2011. 9. Patel, S., Kiefer T.L, Ahmed A., Ali Z.A., Tremmel J.A., Lee D.P., Yeung A.C.,
and Fearon W.F. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. American Journal of Cardiology, 108(11):1552-1555, 2011. 10. Kiefer T.L., Wang A., Hughes G.C., and Bashore T.M. Management of patients
with bicuspid aortic valve disease. Current Treatment Options in Cardiovascular Medicine, 13(6):489-505,2011. 11. Kiefer T.L, Park L., Tribouilloy C., Cortes C., Utilli R., and Wang A.
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. Journal of the American Medical Association, 306(20):2239-2247, 2011. 12. Khazanie P, Rogers JG. Patient selection for left ventricular assist devices.
Congest Heart Fail. 2011 Sep-Oct;17(5):227-34. 13. Mentz RJ, O'Connor CM. Cardiorenal syndrome clinical trial end points. Heart
14. Mudrick DW, Shaw BR, Cowper P, Jensen NC, Drawz MJ, Peterson ED,
Douglas PS. Low yield of cardiac stress testing in the United States. Am Heart J, 2011, in press. 15. Rajagopal S, Rominger DH, Gowen-McDonald W et al. Quantifying ligand bias
at seven-transmembrane recepotrs. Mol Pharmacol 2011 mol.111.072322 [epub ahead of print] 16. Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of beta-arrestin
and G protein-biased agonists. Trends Mol Med 2011;17:126-39. 17. Sastry A, Krucoff MW, Are New DES Designs Safer? Cardiac Interventions
18. Sherwood MW, Wang TY, Becker RC. How Should Patients Requiring Dual
Antiplatelet Therapy be Managed When Undergoing Elective Endoscopic Gastrointestinal Procedures? Curr Treat Options Cardiovasc Med. 2011 Feb;13(1):46-56. 19. Vavalle JP, Granger CB. The need for regional integrated care for ST-segment
elevation myocardial infarction. Circulation. 2011 Aug 16;124(7):851-6. 20. Vavalle JP, Stevens SR, Hassinger N, Cohen MG, Arnold A, Kandzari DE,
Aguirre FV, Gretler DD, Alexander JH. The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial. Am Heart J. 2011 Dec;162(6):996-1002. 1. Ahmad T, Fiuzat M, Felker GM, O’Connor CM. Novel biomarkers in chronic
2. Halim SA, Newby LK, Ohman EM. Biomarkers in cardiovascular clinical trials:
past, present, future. Clin Chem. 2012 Jan;58(1):45-53 3. Robb D. Kociol, MD; Renato D. Lopes, MD, PhD; Robert Clare, MS; Laine
Thomas, PhD; Rajendra H. Mehta, MD, MS; Padma Kaul, PhD; Karen S. Pieper, MS; Judith S. Hochman, MD; W. Douglas Weaver, MD; Paul W. Armstrong, MD; Christopher B. Granger, MD; Manesh R. Patel, MD. International Variation in and Factors Associated With Hospital Readmission After Myocardial Infarction. JAMA 2012;307(1):66-74 4. Mentz RJ, Fiuzat M, Shaw LK, Phillips HR, Borges-Neto S, Felker GM,
O'Connor CM. Comparison of Clinical Characteristics and Long-Term Outcomes of Patients With Ischemic Cardiomyopathy With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). Am J Cardiol. 2012 Feb 8. [Epub ahead of print] 5. Mentz RJ, Fiuzat M, Wojdyla DM, Chiswell K, Gheorghiade M, Fonarow GC,
O'Connor CM. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Fail. 2012 Apr;14(4):395-403. Duke Fellows’ Extramural Grants and Awards

1. NIH K08 2007-12; Matthew Wolf, MD: Genetic modifiers of dilated
2. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease: 2007 International Competitive Grants Award Program for Young Investigators for “Drosophila Genomics and Heart Failure” 3. American Heart Association Fellow to Faculty Career Development Award 2007- 4. Northwestern University Cardiovascular Young Investigator's Competition 2007 - - 2nd place to Deepak Voora, MD (Fellows category),"Pharmacogenetics of LDL cholesterol reduction with statin therapy"
2008

1. ACC/Merck Cardiovascular Research Fellowship, 2008-2009 to Deepak Voora,
2. AHA Mid-Atlantic Affiliate Post-Doctoral Award, 7/08-6/09; Chetal Patel, MD: “B-arrestin-Biased B1-Adrenergic Receptor Signaling” 3. Northwestern University Cardiovascular Young Investigator's Competition 2008 - - 2nd place to Deepak Voora, MD (Fellows category), "Using a comparative
genomics approach to identify polymorphisms in calumenin as predictors of
warfarin dose"
4. ACC/Merck Cardiovascular Research Fellowship, 2008-2009; Jonathon Piccini, MD: Safety of Sotalol Pharmacotherapy in Patients with Atrial Fibrillation 5. Society for Nuclear Medicine Cardiovascular Council Young Investigator Award, 2008 to Jonathon Piccini MD
6. Northwestern Cardiovascular Young Investigators’ Forum, 2008—1st place to Jonathon Piccini, MD

2009
1. Fogarty International Clinical Research Fellowship, July 1 2009 to June 30 2010;
Gerald Bloomfield, MD, MPH: The prevalence of the markers of atherosclerosis
among patient with heart failure in Kenya.
2. Schering Plough LCIC grant, 2009; Sudar Rajagopal MD, PhD, "Effects of
beta-Adrenergic Receptor Polymorphisms on Noncanonical GPCR Signaling and Responses to Beta Blockers after Acute Coronary Syndrome" 3. NIH K08, 2009-14; Gregory Lam, MD, PhD: “A novel role of protein S-
nitrosylation in skeletal muscle angiogenesis” 1. ACCF/Herman K. Gold Young Investigator Award in olecular and Cellular Cardiology; Sudar Rajagopal, MD, PhD: “Beta-arrestins regulate signaling by
type II bone morphogenetic protein receptor in pulmonary arterial hypertension”,
April 2011.
2. American Philosophical Society Daland Fellowship in Clinical Investigation; Tariq Ahmad, MD, MPH: Biomarkers in heart failure, December 2011.

Source: http://fellowships.medicine.duke.edu/sites/fellowships.medicine.duke.edu/files/Fellows%20Publications%202006-12.pdf